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Danshen has been used in traditional Chinese medicine for hundreds of years to treat 
cardiovascular diseases. However, its precise cardioprotective components and the underlying 
mechanism are still unclear. In the present study, we demonstrated that in a rat model of acute 
myocardial infarction, the treatment with magnesium lithospermate B (MLB), the representative 
component of phenolic acids in Danshen, significantly reduced the infarct size and the blood 
lactate dehydrogenase level. In contrast, tanshinone IIA, the representative component of 
lipophilic tanshinones in Danshen, had no such protective effects. Moreover, in the simulated 
ischemia cell model, MLB treatment considerably increased the cell viability and reduced 
the sub-G1 population and the apoptotic nuclei, indicating its anti-apoptotic effect. Further 
mechanism study revealed that the ischemia-induced p38 phosphorylation was abolished by 
MLB treatment. Interestingly, MLB specifically inhibited the TGFβ-activated protein kinase 
1-binding protein 1 (TAB1) mediated p38 phosphorylation through disrupting the interaction 
between TAB1 and p38, but it did not affect the mitogen-activated protein kinase 3/6 mediated 
p38 phosphorylation. In conclusion, the present study identifies MLB as an active component 
of Danshen in protecting cardiomyocytes from ischemic injury through specific inhibition of 
TAB1–p38 apoptosis signaling. These results indicate TAB1–p38 interaction as a putative drug 
target in treating ischemic heart diseases.
Keywords: magnesium lithospermate B, ischemia, apoptosis, p38, TAB1
Edited by:
Tong-Hui Ma, Jilin University, China
Reviewed by:
Hong Yang, Liaoning Normal University, 
China
Yuanjian Li, Huanan University of 
Science and Technology, China
*Correspondence:
Xin Xie, Shanghai Institute of Materia 
Medica, 189 Guo Shou Jing Road, 
Shanghai 201203, China.  
e-mail: xxie@mail.shcnc.ac.cn and
Ding-Feng Su, Department of 
Pharmacology, School of Pharmacy, 
Second Military Medical University, 
325 Guo-He Road, Shanghai 200433, 
China.
e-mail: dfsu2008@gmail.com
and Gattinger, 1996; Liu et al., 2009). p38, one of the key factors in 
the mitogen-activated protein kinase (MAPK) signaling pathway, 
is activated during simulated ischemia and reperfusion (Ma et al., 
1999). Pharmacological inhibition of p38 protects cardiomyocytes 
from apoptosis during simulated ischemia in vitro (Cheng, 2006). 
Interestingly, this p38 phosphorylation and activation are independ-
ent of the upstream mitogen-activated protein kinase kinase (MKK) 
3/6, but dependent on the autophosphorylation of p38 through its 
interaction with TGFβ-activated protein kinase 1-binding protein 1 
(TAB1) (Ge et al., 2002; Tanno et al., 2003). Thus, inhibition of the 
TAB1–p38 mediated apoptosis signaling has been implicated to be 
a potential way for the treatment of ischemic heart diseases.
In the present study, we investigated the protective effects of two 
representative components of Danshen, magnesium lithospermate 
B (MLB) and tanshinone IIA, in experimental models of ischemia. 
We demonstrate that MLB acts as one of the major active compo-
nents of Danshen in protection of cardiomyocytes from ischemic 




Sprague-Dawley (SD) rats were purchased from the Experiment 
Animal Center, Chinese Academy of Sciences in Shanghai. All ani-
mals were maintained under pathogen-free conditions prior to use. 
introduction
Danshen, the rhizome of Salvia miltiorrhiza, is one of the famous 
ancient Chinese herbal medicines and is traditionally believed to 
“invigorate” the blood and reduce blood clotting. Remedies con-
taining Danshen have been used customarily to treat coronary heart 
diseases, particularly angina pectoris and myocardial infarction 
(MI) (Ji et al., 2000). Although Danshen is officially listed in the 
Chinese Pharmacopoeia and is used widely and successfully in clin-
ics in China, the exact mechanism for its therapeutic basis is poorly 
understood. Over the last 50 years, the chemical constituents and 
biological activities of Danshen have been widely studied. To date, 
more than 60 ingredients have been identified in Danshen, which 
are mainly divided into water-soluble phenolic acids and lipophilic 
tanshinones (Wang et al., 2007). Phenolic acids possess antioxidant 
and anticoagulant activities, whereas tanshinones show antibacte-
rial, antioxidant, and antineoplastic activities. However, the main 
active component with cardioprotective effects on ischemic heart 
diseases and the underlying mechanism remain unresolved.
Ischemic heart diseases are characterized by an inadequate blood 
flow to the heart, which lead to limited availability of glucose and 
oxygen, delayed clearance of metabolic wastes and eventually mas-
sive death of cardiomyocytes. Earlier investigation indicated that 
cardiac ischemic injury is due to cell necrosis. More recently, apop-
tosis has been implicated in many forms of cardiac pathology and 
plays major roles in ischemia-induced cardiomyocytes death (Fliss Frontiers in Pharmacology | Ethnopharmacology    August 2010  | Volume 1  |  Article 111  |  2
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Facs
The cells were harvested and washed with PBS (pH 7.2) twice 
and suspended in 80% ethanol at −20°C for 24 h. The cells were 
then thawed at room temperature, washed twice with PBS and re-
suspended in the extraction buffer (0.2 M Na2HPO4, 0.1 M citric 
acid) for 5 min. The cells were stained with 50 μg/ml propidium 
iodide in PBS containing RNase A (100 μg/ml) for 30 min. The cell 
cycle distribution and quantitation of apoptotic cells were meas-
ured by a FACS calibur flow cytometer (Becton-Dickinson) (Du 
et al., 2004).
Mts assay
The viability of cultured cells was evaluated by MTS assay (Promega) 
as previously described (Jing et al., 1999). Cells were seeded onto 
the 96-well plates at a density of 5000–10,000 cells/100 μl/well over-
night. After treatment of various reagents, the cells were subjected to 
simulated ischemia for indicated time period. 20 μl of MTS solution 
was then added and cells were incubated at 37°C for 4 h. Absorbance 
at 490 nm was measured using a microplate reader.
terMinal deoxynucleotidyl transFerase dutP nick 
end‑labeling (tunel)
TUNEL was applied to detect DNA fragmentation that results from 
apoptotic signaling cascades. Cells were grown on glass cover slips 
for 24 h. Cells were then subjected to simulated ischemia for indi-
cated time period and fixed with 4% polyformaldehyde. Cells were 
washed and permeabilized with 0.2% Tween in PBS containing 
0.2% BSA. After fluorescein staining with TdT end-labeling cock-
tail (TdT buffer, Biotin-dUTP, and TdT) and avidin-FITC, DNA 
fragmentation was analyzed on a fluorescence microscope. Analysis 
of tissue samples was performed according to the manufacturer’s 
instructions (Upstate).
Western blot analysis
Proteins were denatured, resolved on SDS-PAGE gels, and trans-
ferred onto nitrocellulose membranes. Primary antibodies were 
added at the recommended dilutions. Detection was performed 
with IRDyeTM800CW-conjugated secondary antibody and the 
infrared fluorescence image was obtained using the Odyssey infra-
red imaging system (Li-Cor Bioscience). In some experiments, pro-
tein bands were visualized by enhanced chemiluminescence.
iMMunoPreciPitation and in vitro p38 activity assay
After simulated ischemia, cells or homogenized heart tissues were 
lysed with ice cold immunoprecipitation buffer. Cell lysates were 
incubated with a total p38 antibody overnight at 4°C and then pre-
cipitated with protein A agarose beads for 2 h at 4°C. The beads 
were washed five times with lysis buffer and recombinant activating 
transcription factor-2 (ATF-2) fusion protein was added. p38 activity 
in immunoprecipitates was assessed by Western blot analysis of phos-
pho-transcription factor-2 (Jing et al., 1999; Bonta et al., 2009).
statistical analysis
Results of the experiments were expressed as means ± S.E.M. 
Student t-test was performed for the statistical analysis of results. 
For all tests, a P-value less than 0.05 was considered statistically 
significant.
Male rats weighing 180–220 g were anesthetized with pentobarbital 
sodium (50 mg/kg) given intraperitoneally before surgery. All ani-
mal experiments were in accordance with the National Institutes 
of Heath Guide for the Care and Use of Laboratory Animals and 
were approved by Biological Research Ethics Committee, Shanghai 
Institutes for Biological Sciences, Chinese Academy of Sciences.
rat ischeMia Model
Rat ischemia model was established by the left anterior descending 
artery (LAD) ligation as previously described (Connolly et al., 2006; 
Hu et al., 2009; Wang et al., 2009a). Briefly, after intraperitoneal drug 
administration, male SD rats were anesthetized and placed in dorsal 
decubitus supine position and a left thoracotomy was performed at 
the 5th intercostal space under aseptic surgical conditions. An inter-
costal retractor was positioned to maintain free access to the heart. The 
apex of the heart was partially positioned outside the thorax and the 
LAD was ligated approximately 2 mm from its origin. The heart was 
repositioned inside the thorax, which was subsequently closed. The air 
in the pneumothorax was then gently reduced by external compres-
sion. After breathing recovery, the animals were housed individually 
until the end of the experiment. Sham operated controls were treated 
in an identical fashion including administration of anesthesia but did 
not undergo ligature tie off. At the end of LAD ligation, the area at risk 
and infarct size of the left ventricular tissue sections was assessed by 
NBT staining as previously described (Zacharowski et al., 1999). The 
blood samples were collected 1 h after LAD ligation and serum lactate 
dehydrogenase level was measured spectrophotometrically using a 
lactate dehydrogenase assay kit (Shanghai Chemical Reagent Research 
Institute) according to the manufacturer’s instructions.
cell cultures and reagents
H9c2 cell (passage 18–25; American Type Culture Collection, 
Rockville, MD, USA), a clonal line derived from embryonic rat 
heart, was cultured in DMEM (Gibco-BRL) supplemented with 
10% (v/v) heat inactivated fetal bovine serum and antibiotics, under 
an atmosphere of 95% air and 5% CO2 at 37°C. “Danshen Injection” 
was from Shanghai No.1 Biochemical Pharmacological Company. 
MLB with 100% purity and MLB with 83.2% purity used in cell 
model and animal models respectively were supplied by Shanghai 
Institute of Materia Medica, Chinese Academy of Sciences. Other 
reagents were from Sigma.
siMulated ischeMia in vitro
H9c2 cardiac myocytes were exposed to simulated ischemia as 
described (Fiedler et al., 2006; Wang et al., 2009b). In brief, the cells 
were switched from maintenance medium to an ischemic buffer 
and were incubated in a hypoxia chamber flushed with 5% CO2 and 
95% N2 for indicated period of time. Control cells were cultured in 
a normal buffer and incubated at 37°C in an atmosphere containing 
5% CO2 and 95% room air (normoxia).
iMMunoFluorescence MicroscoPy
Heart tissue sections were incubated with primary antibodies 
against total p38 or phosphorylated p38 and subsequently with an 
FITC-conjugated secondary antibody. Images were acquired with 
a confocal fluorescence microscope (Leica TCS SP2) as previously 
described (Kang et al., 2005).www.frontiersin.org  August 2010  | Volume 1  |  Article 111  |  3
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Mlb treatMent inhibits aPoPtosis in ischeMic cell Model 
and rat heart
It has been demonstrated that cell apoptosis is one of the major 
causes of cardiomyocyte injury during ischemic insults (Fliss 
and Gattinger, 1996). So we tested the ability of MLB in inhibit-
ing ischemic induced apoptosis. H9c2 is a cardiac myoblasts cell 
line that is widely used to study the ischemic myocardial injuries 
in vitro (Bonavita et al., 2003; Agnetti et al., 2005). TUNEL assay 
revealed that simulated ischemia triggered apoptosis in about 35% 
of H9c2 cells. But in 10 μM and 30 μM MLB treatment groups, cell 
apoptosis was remarkably reduced to 22% and 12%, respectively 
(Figures 2A,B). This protection effect of MLB on H9c2 apopto-
sis was further validated by the FACS analysis. The percentage of 
sub-G1 cells were commonly used as a measure of apoptosis. Results 
indicated, at both 10 and 30 μM concentrations, MLB significantly 
reduced the sub-G1 population of H9c2 cells in simulated ischemia 
(Figure 2C). Moreover, TUNEL staining revealed cardiomyocytes 
apoptosis in the infarcted rat hearts was also inhibited by MLB 
treatment (Figure 2D), supporting the cardioprotection role of 
MLB in vivo.
Mlb inhibits ischeMia‑induced aPoPtosis by inhibiting p38 
PhosPhorylation and activation
MAPKs play important roles in the ischemic injury of cardiomyo-
cytes (Armstrong, 2004). In order to explore the potential signal-
ing pathways involved in MLB-mediated cardioprotection, the 
H9c2 cells were pretreated with three types of MAPK   inhibitors 
results
Mlb treatMent attenuates ischeMic heart injury in rat
In order to test the protective effect of Danshen in myocardial 
ischemic injury, rat ischemia model was established by 1 h LAD 
ligation. “Danshen Injection,” a total extraction from Danshen (Wu 
et al., 2007), MLB and tanshinone IIA, two representative compo-
nents of Danshen, were applied just before the surgery at a dosage 
normalized to their natural composition in the plant (Figure 1). 
Compared to normal saline treated group, the heart infarct sizes 
in “Danshen Injection” and MLB (10 mg/kg) treated rats were 
reduced by 24.5% and 23.6% respectively, which is more effec-
tive than the control with a first-line drug nitroglycerin (30 mg/
kg, infarct size reduction about 15%) (Figures 1A,B). In contrast, 
tanshinone IIA had no effect on reducing the infarct size. The 
reduction of the infarct area by MLB treatment was very significant 
and the differences can be clearly observed by visual examination 
(Figure 1C). The heart area at risk of acute MI was comparable 
between the normal saline group and drug treatment groups (data 
not shown). Blood samples were collected after 1 h LAD ligation 
and blood lactate dehydrogenase level, another marker for heart 
impairment during the MI (Garlid et al., 1997), was found to 
increase by 2.1-folds in the normal saline treatment group com-
pared to the sham operation group. This increase was inhibited 
by MLB or “Danshen Injection” treatment but not by tanshinone 
IIA (Figure 1D). These data demonstrate that MLB acts as one of 
the major active components of Danshen in protection of cardio-
myocytes from ischemic injury.
Figure 1 | MLB treatment attenuates ischemic injury in rat myocardial 
infarction (Mi) animal model. (A) Rats were intraperitoneally injected with 
normal saline (NS), tanshinone IIA (TIIA, 1 mg/kg), nitroglycerin (NG, 30 mg/kg), 
“Danshen Injection” (DSI, 120 μl/kg) and MLB (1–10 mg/kg), before LAD ligation. 
Heart infarct size was assessed after 1 h global ischemia by LAD ligation as a 
percentage of total left ventricular weight (%LV). (B) Infarct inhibition ratio by 
medicine treatment is depicted as a percentage of reduced infarct size 
compared to the infarct size in NS group. (C) Representative pictures of NS or 
MLB (10 mg/kg) treated rat MI hearts (red indicates the infracted area). 
(D) Lactate dehydrogenase (LDH) level in animal blood samples from (A). 
n = 8∼10; #, P < 0.001 compared with sham group. *P < 0.05; **P < 0.01 
compared with NS group.Frontiers in Pharmacology | Ethnopharmacology    August 2010  | Volume 1  |  Article 111  |  4
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exert its cardioprotective effect by inhibiting p38 signaling path-
way. Western blot analysis was carried out to further validate this 
hypothesis. As shown in Figures 3D,E, pretreatment with MLB 
dose-dependently blocked ischemia-induced elevation of phos-
phorylated p38 level. In contrast, MLB had no effect on ischemia-
induced ERK and JNK phosphorylation (Figures 3D,E). Similar 
results were obtained when infarcted rat hearts were subjected to 
Western blot analysis (Figures 4A,B). MLB significantly reduced 
ischemia-induced p38   phosphorylation but did not affect ERK 
before simulated ischemia treatment. Interestingly, neither ERK 
inhibition by PD98059 nor JNK inhibition by SP600125 prevented 
cell death induced by ischemic injury (Figure 3A). However, p38 
inhibition by SB203580 significantly increased cell viability to 
a similar extent as observed in MLB treatment. Furthermore, 
when cells were treated with MLB and SB203580 simultaneously, 
no additive or synergistic protection effects were observed. Cell 
apoptosis analyzed by TUNEL and FACS supports the MTS 
results (Figures 3B,C). These results suggest that MLB might 
Figure 2 | MLB inhibits apoptosis in simulated ischemia treated H9c2 
cells and ischemic rat hearts. (A) H9c2 cells were pretreated with NS or 
MLB (3–30 μM) for 30 min and subjected to simulated ischemia (16 h). Cell 
apoptosis was assessed by TUNEL assay. The mock treated cells were 
shown as control (CON). DAPI staining was used to reveal the total cell 
number. (B) Quantitative presentation of the TUNEL analysis shown in 
(A). Values are shown as a percentage of the TUNEL positive cell number to 
the total cell number. (C) Cell apoptosis assessed by FACS analysis. Cells 
were stained with propidium iodide and apoptosis was measured as the 
percentage of sub-G1 cells. (D) TUNEL assay was performed in rat hearts 
subjected to 24 h LAD ligation. Animals were pretreated with NS or MLB 
(10 mg/kg). Data shown were pooled from three independent experiments. 
#, P < 0.001 compared with sham group. *P < 0.05; **P < 0.01 compared 
with NS group.www.frontiersin.org  August 2010  | Volume 1  |  Article 111  |  5
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Direct measurement of p38 kinase activity was also carried out 
with immunoprecipitated p38 from ischemic rat hearts and recom-
binant ATF-2 was used as a substrate (Figures 4E,F). In agreement 
with our previous observation, ischemia clearly stimulated p38 
phosphorylation as well as the phosphorylation of its substrate 
ATF2, whereas MLB inhibited this phosphorylation and therefore 
the activity of p38.
and JNK phosphorylation in rat hearts. Immunofluorescence 
staining of phosphorylated p38 in infarcted rat hearts clearly 
demonstrated that MLB treatment dramatically reduced p38 
phosphorylation (Figures 4C,D).
It has been established that p38 is activated by dual phosphoryla-
tion at 180Thr and 182Tyr residues (Jing et al., 1999), and the phos-
phorylation of p38 has been widely used to represent its  activation. 
Figure 3 | MLB inhibits simulated ischemia-induced apoptosis by 
inhibiting p38 phosphorylation in H9c2 cells. (A–C) H9c2 cells were 
pretreated with 10 μM SP600125 (SP , JNK inhibitor), 10 μM PD98059 (PD, ERK 
inhibitor), 1 μM SB203580 (SB, p38 inhibitor) and 30 μM MLB for 30 min and 
then subjected to simulated ischemia for 16 h. (A) Cell viability was determined 
by MTS assay. (B,C) Cell apoptosis was assessed by TUNEL assay and FACS 
analysis. (D) For Western blot analysis, H9c2 cells were pretreated with 30 μM 
MLB for 30 min and then subjected to simulated ischemia for 3 h. MAPKs 
phosphorylation was detected with specific antibodies against total and 
phosphorylated MAPKs (p38, ERK, JNK). Actin was also detected as a loading 
control. (e) Quantitative analysis of Western blot was performed with Scnimage 
software. Data shown are pooled from three independent experiments. #, 
P < 0.001 compared with the group without ischemia treatment. *P < 0.05; 
**P < 0.01 compared with ischemia treatment group.Frontiers in Pharmacology | Ethnopharmacology    August 2010  | Volume 1  |  Article 111  |  6
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Figure 4 | MLB inhibits p38 phosphorylation and activation in ischemic rat 
heart. MAPKs phosphorylation in ischemic (1 h) rat heart tissues were analyzed 
by Western blot (A) or immunofluorescence assay (C). Antibodies against total 
and phosphorylated MAPKs (p38, ERK, JNK) were applied. Detection of actin 
served as a loading control. Quantitative analysis of Western blot was performed 
with ScnImage software (B). Quantification of immunofluorescence was 
performed with Image-pro software (D). Data shown are pooled from three 
independent experiments. (e,F) Whole rat hearts were homogenized 1 h after 
LAD ligation, and total p38 was immunoprecipitated with an anti-p38 antibody. 
Phosphorylated p38 and total p38 were analyzed by Western blot (e). P38 kinase 
activity was assessed in vitro by its ability to phosphorylate ATF-2 (F), #, P < 0.05 
compared with sham group. *P < 0.05 compared with ischemia treatment group.
Mlb inhibits ischeMic induced p38 PhosPhorylation and 
activation by disruPting tab1–p38 interaction
In the MAPK activation cascade, p38 is generally phosphorylated 
and activated by MKK3/6 (Chang and Karin, 2001). In order to 
illustrate whether MKK3/6 is involved in the phosphorylation inhi-
bition of p38 by MLB, sorbitol and TNF, which were reported to 
induce MKK3/6-dependent p38 phosphorylation (Wysk et al., 1999; 
Tanno et al., 2003), were applied. Strikingly, MLB treatment did 
inhibit the ischemia stimulated p38 phosphorylation but not sorbi-
tol or TNF-stimulated p38 phosphorylation (Figure 5A). Similar 
results were obtained with SB203580, an inhibitor of p38 signaling 
which specifically inhibits ischemia-induced p38 phosphorylation, 
but not MKK3/6-mediated p38 phosphorylation (Gum et al., 1998). 
These findings suggest that MLB might function through a non-
MKK3/6 pathway to interfere the p38 signaling.
Recently, a MKK3/6-independent model of p38 activation has 
been described where the scaffold protein TAB1 promotes p38 
autophosphorylation through interaction with p38 (Ge et al., 
2002). This TAB1 mediated p38 phosphorylation and activation 
has been demonstrated to play important roles in ischemia-induced 
heart injuries (Ge et al., 2002; Tanno et al., 2003; Li et al., 2005; 
Fiedler et al., 2006). Therefore, we tested the possibility whether 
MLB inhibits ischemia-induced p38 phosphorylation by interfer-
ing TAB1–p38 interaction. Consistent with the previous report 
(Tanno et al., 2003), we observed that ischemia (3 h) markedly 
stimulated p38 phosphorylation and its interaction with TAB1 in 
H9c2 cells (Figures 5B,C, lane 4). In contrast, TAB1–p38 inter-
action was not observed in H9c2 cells treated with sorbitol or 
TNF (data not shown), indicating that TAB1–p38 interaction is 
not regulated by MKK3/6 signaling. Interestingly, the TAB1–p38 www.frontiersin.org  August 2010  | Volume 1  |  Article 111  |  7
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Figure 5 | MLB inhibits ischemia-induced TAB1–p38 interaction in H9c2 
cells and rat hearts. H9c2 cells were pretreated with MLB (30 μM) or 
SB203580 (1 μM) for 30 min, then exposed to ischemia (3 h), sorbitol (0.1 M, 
30 min), or TNF (10 ng/ml, 15 min) treatment. Total cell extracts were 
analyzed by Western blot for p38 phosphorylation (A). Simultaneously, cell 
lysate was immunoprecipitated with p38 (B) or TAB1 (C) -specific antibodies 
and the precipitates were analyzed for the presence of TAB1 or p38 by 
Western blot analysis. (D,e) Co-immunoprecipitation was performed with 
whole rat heart extract 1 h after LAD ligation and analyzed as described in 
(B) and (C).
interaction stimulated by ischemia was almost completely disrupted 
by MLB treatment (Figures 5B,C, lane 5). In contrast, SB203580, 
which inhibits p38 activity through binding to its kinase activity 
domain, had little influence on the interaction (Figures 5B,C, lane 
6). We next examined whether MLB is also able to reduce TAB1–p38 
interaction caused by MI in rat heart. As shown in Figures 5D,E, 
ischemia remarkably enhanced the interaction between p38 and 
TAB1, which was disrupted by MLB.
Taken together, our results demonstrate that MLB, one of the 
major active components of Danshen, protects myocardial injuries 
from ischemic insults in both animal and cell models. This pro-
tective effect of MLB is related to its ability to specifically inhibit 
ischemia-induced TAB1–p38 apoptosis signaling pathway.
discussion
Danshen has been widely used in China and, to a lesser extent, 
in Japan, the United States, and other European countries for the 
treatment of cardiovascular and cerebrovascular diseases. It has 
also been indicated for chronic hepatitis and liver fibrosis treatment 
(Liu et al., 2000), as well as inflammatory diseases such as lethal 
sepsis (Wan et al., 2006). The chemical constituents of Danshen 
are divided mainly into water-soluble phenolic acids and lipophilic 
tanshinones (Wang et al., 2007). The phenolic acids have diversed 
biological activities including antioxidation, anti-blood coagula-
tion, vasodilation, cell protection, etc. Recent research revealed 
additional anti-tumor activity and anti-HIV activity of the phenolic 
acids (Jiang et al., 2005). The lipophilic tanshinones are also found 
to possess a variety of pharmacological activities such as antibacte-
ria, antioxidation, anti-inflammatory and anti-tumor formation.
In the present study we demonstrate that MLB, the representa-
tive component of the water soluble phenolic acids in Danshen, 
has similar cardioprotective activity in the rat model of ischemia 
compared to the crude Danshen extract when used at a normal-
ized dosage. In contrast, the tanshinone IIA has little effect when 
applied at a dosage comparable to its concentration within crude 
Danshen extract. Therefore, MLB, the representative of phenolic Frontiers in Pharmacology | Ethnopharmacology    August 2010  | Volume 1  |  Article 111  |  8
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